Results 21 to 30 of about 116,971 (308)

Anticoagulation Therapy

Hematology, 2001
Abstract Despite refinements and standardization in the use of anticoagulants, many problems remain for clinicians. Dr. Crowther describes appropriate starting and maintenance doses of warfarin, factors accounting for inter- and intra-observer variability and importantly, the management of the over-anticoagulated patients and bleeding ...
J A, Ginsberg, M A, Crowther, R H, White, T L, Ortel   +3 more
openaire   +2 more sources

Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review

Clinical Case Reports, 2022
Renal infarction is an underdiagnosed condition with multiple possible causes, including atrial fibrillation. The treatment approach includes percutaneous endovascular therapy (PET) to restore blood flow, antiplatelet therapy, anticoagulation, or ...
Anas Al‐sadi, Mohammed Abdulgayoom, Mohammed Alamin, Jouhar Kolleri, Israa Jawarneh, Qusai Almaharmeh   +5 more
doaj   +1 more source

A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation

Frontiers in Pharmacology, 2023
Background: Oral anticoagulants (OACs) are essential for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). However, the appropriateness of anticoagulation treatment in locally practice remains unclear.
Xiao-Yuan Zheng, Guang-Wei Feng, Jing Guo, Fen Xie, Xia Li, Ming-Zhu Zhang, Ming-Zhu Zhang, Xiu-Fen Zhang, Xiu-Feng Wu, Yong-Juan Ding   +9 more
doaj   +1 more source

Remote care instruction via the WeChat platform for female patients receiving subcutaneous anticoagulation during the COVID-19 pandemic: a retrospective analysis [PDF]

PeerJ
Background The purpose of this study was to estimate the effect of remote nursing guidance based on WeChat platform for female patients receiving subcutaneous anticoagulation during the COVID-19 epidemic.
Chao Yun Jiang, Ci Juan Li, Rong Zhang, Tian Hong Cai, Teng Hui Zhan   +4 more
doaj   +2 more sources

Low-Intensity vs. High-Intensity Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Meta-Analysis of Randomized Controlled Trials

Structural Heart, 2023
Background: The optimal antithrombotic therapy after transcatheter aortic valve replacement (TAVR) is controversial. We performed a systematic review and meta-analysis of randomized controlled trials comparing high-intensity vs.
Tarun Chakravarty, MD, Derek Leong, MD, Angelo de la Rosa, MD, Neel Bhardwaj, BS, Raj R. Makkar, MD   +4 more
doaj   +1 more source

Anticoagulant therapy and pregnancy [PDF]

Reproductive Medicine and Biology, 2008
Low dose aspirin therapy is one of the anticoagulant treatments used during pregnancy. Anticoagulant agents may be useful for several disorders, such as recurrent miscarriage, pre‐eclampsia, fetal growth restriction and infertility. However, it is unclear whether anticoagulant therapy can increase the live birth rate in all of these cases.
Aiko, Makino, Mayumi, Sugiura-Ogasawara
openaire   +2 more sources

Sinovenous Thrombosis: Anticoagulation Therapy

Pediatric Neurology Briefs, 1998
The value of anticoagulant therapy in a consecutive cohort 5 year study of 30 children with 32 episodes of sinovenous thrombosis (SVT) was assessed at the Hospital for Sick Children, Toronto, Canada.
J Gordon Millichap
doaj   +1 more source

Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillation

BMC Cardiovascular Disorders, 2023
Background The clinical benefits and risks of anticoagulation therapy in patients with chronic kidney disease (CKD) are still inconclusive. We describe the outcomes of patients with atrial fibrillation (AF) after anticoagulation therapy according to ...
Min Soo Cho, Hyung Oh Choi, Ki Won Hwang, Jun Kim, Gi-Byoung Nam, Kee-Joon Choi   +5 more
doaj   +1 more source

Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients

EClinicalMedicine, 2021
Background: Coronavirus disease 2019 (COVID-19) is associated with a hypercoagulable state. Limited data exist informing the relationship between anticoagulation therapy and risk for COVID-19 related hospitalization and mortality.
Sameh M. Hozayen, Diana Zychowski, Sydney Benson, Pamela L. Lutsey, Jasmin Haslbauer, Alexandar Tzankov, Zachary Kaltenborn, Michael Usher, Surbhi Shah, Christopher J. Tignanelli, Ryan T. Demmer   +10 more
doaj   +1 more source

Rational and safe dosing of phenprocoumon during loading and maintenance phase [PDF]

, 2012
Phenprocoumon is the second most commonly used oral anticoagulant worldwide and the most common agent in many European countries including Switzerland. Given its long half-life of about one week, an initial loading-dose is generally applied. A high
Caduff Good, Angela
core   +1 more source